−2.280EUR
−11.01 MEUR
106.34 MEUR
4.06 M
About DR. HOENLE AG O.N.
Sector
Industry
CEO
Franz Richter
Website
Headquarters
Gilching
Employees (FY)
594
Founded
1976
ISIN
DE0005157101
FIGI
BBG000F69W54
Dr. Hönle AG engages in the development, manufacture, and sale of light-emitting diode ultraviolet (UV) products. It operates through the following segments: Equipment and Systems; Adhesives; and Glass and Lamps. The Equipment and Systems offers UV products that are used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and sunlight simulation. The Adhesive segment includes industrial adhesives for a spectrum of applications. The Glass and Lamp segment comprises of quartz glass tubing and rods for the lamp, automotive, semiconductor, and fibre cable industries as well as lamps for water sterilization and drying of coatings and adhesives. The company was founded by Karl Hönle and Günter Schmid in 1976 and is headquartered in Gilching, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of HNL is 19.650 EUR — it has decreased by 0.51% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BER exchange DR. HOENLE AG O.N. stocks are traded under the ticker HNL.
DR. HOENLE AG O.N. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
HNL stock is 0.51% volatile and has beta coefficient of 0.92. Check out the list of the most volatile stocks — is DR. HOENLE AG O.N. there?
One year price forecast for DR. HOENLE AG O.N. has a max estimate of 29.000 EUR and a min estimate of 23.400 EUR.
DR. HOENLE AG O.N. revenue for the last quarter amounts to 26.60 M EUR despite the estimated figure of 26.60 M EUR. In the next quarter revenue is expected to reach 23.80 M EUR.
Yes, you can track DR. HOENLE AG O.N. financials in yearly and quarterly reports right on TradingView.
HNL stock has risen by 0.26% compared to the previous week, the month change is a 8.56% rise, over the last year DR. HOENLE AG O.N. has showed a 5.53% decrease.
HNL net income for the last quarter is −901.00 K EUR, while the quarter before that showed −4.38 M EUR of net income which accounts for 79.43% change. Track more DR. HOENLE AG O.N. financial stats to get the full picture.
Today DR. HOENLE AG O.N. has the market capitalization of 120.63 M, it has decreased by 1.24% over the last week.
Like other stocks, HNL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DR. HOENLE AG O.N. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 594.00 employees. See our rating of the largest employees — is DR. HOENLE AG O.N. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DR. HOENLE AG O.N. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DR. HOENLE AG O.N. stock shows the sell signal. See more of DR. HOENLE AG O.N. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on DR. HOENLE AG O.N. future price: according to them, HNL price has a max estimate of 29.00 EUR and a min estimate of 23.40 EUR. Read a more detailed DR. HOENLE AG O.N. forecast: see what analysts think of DR. HOENLE AG O.N. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DR. HOENLE AG O.N. EBITDA is −2.78 M EUR, and current EBITDA margin is −0.77%. See more stats in DR. HOENLE AG O.N. financial statements.